Browse by Glasgow Author

Jump to: 2019 | 2018 | 2017 | 2015 | 2013 | 2010
Number of items: 13.

2019

Bilsland, A. , Boyd, S., Turnbull, A., Jenkinson, D., Roffey, J. and Keith, N. (2019) Theoretical model of complex between phosphoglycerate kinase 1 and DJ1. [Data Collection]

Ross, K., Keith, N. , Aitchison, I., Allbutt, E., Banks, E., Basra, S., Bilsland, A., Charalambous, A., Chapal, C., Drummond, M., Dunipace, S., Erridge, A., Fremin-Besombes, M., Glasspool, R., Hamilton, V., Hanna, C. , Herfurth, L., Humpleby, M., Hush, G., Ivanova, Y., Jones, R. , Kaleta-Pyrek, A., Kalt, L., Kantor, M., Karolak, G., Keith, A., Klink, S., Laing, B., Lister, A., Mallon, E., Mccann, E., McLaughlin, R., Merchant, Z., Mozel, A., Mrozek, O., Painter, C., Paul, J. , Paxton, J., Perry, M. , Prendergast, E., Proudfoot, B., Raina, T., Roberts, F., Safrany, S., Scott, J., Sleight, R., Smith, C., Strain, E., Stricevic, M., Svanera, S., Tobias, E. , Vansteenhouse, H., Williams, N. and Zhang, H. (2019) A collaborative approach to exploring the future of Cancer treatment and care in relation to Precision Medicine: A design perspective. [Data Collection]

2018

Sumpton, D., Keith, N. and Bilsland, A. (2018) Identification of novel pyrazolopyrimidine compounds that modulate the shelterin complex and telomere length regulation via phosphoglycerate kinase 1 and stress sensor DJ1. [Data Collection]

Turnbull, A. P., Bilsland, A., Liu, Y., Sumpton, D., Stevenson, K., Cairney, C., Roffey, J., Jenkinson, D. and Keith, N. (2018) PGK1 in complex with CRT0063465 (3-[2-(4-bromophenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-6-yl]propanoic acid). [Data Collection]

2017

Keith, N. and Bilsland, A. (2017) Confirmatory assay for modulation of the human telomerase reverse transcriptase promoter in HCT116 cells. [Data Collection]

Keith, N. and Bilsland, A. (2017) Confirmatory dose-response cell survival assay for modulators of telomere damage signalling. [Data Collection]

Keith, N. and Bilsland, A. (2017) Luciferase assay for modulation of the human telomerase RNA component promoter. [Data Collection]

Cairney, C., Godwin, L., Bilsland, A., Burns, S., Stevenson, K., McGarry, L., Revie, J., Moore, J., Wiggans, C., Collinson, R., Mudd, C., Tsonou, E., Sadaie, M., Bennet, D., Narita, M., Torrance, C. and Keith, N. (2017) A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds. [Data Collection]

Keith, N. and Bilsland, A. (2017) Cell survival assay for modulators of telomere damage signalling. [Data Collection]

Keith, N. and Bilsland, A. (2017) Luciferase assay for modulation of the human telomerase reverse transcriptase promoter. [Data Collection]

2015

Bilsland, A., Pugliese, A., Liu, Y., Revie, J., Burns, S., McCormick, C., Cairney, C., Bower, J., Drysdale, M., Narita, M., Sadaie, M. and Keith, N. (2015) Identification of a selective G1-phase benzimidazolone inhibitor by a senescence-targeted virtual screen using artificial neural networks. [Data Collection]

2013

Bilsland, A. (2013) Statespaceminer app. [Data Collection]

2010

Lafferty-Whyte, K., Bilsland, A., Hoare, S., Burns, S., Zaffaroni, N., Cairney, C. and Keith, N. (2010) TCEAL7 Inhibition of c-Myc Activity in Alternative Lengthening of Telomeres Regulates hTERT Expression. [Data Collection]

This list was generated on Mon Mar 18 04:54:16 2024 GMT.